News

ImmunoPrecise Antibodies Ltd. ( NASDAQ: IPA) Q4 2025 Earnings Call July 29, 2025 10:30 AM ET Jennifer Lynne Bath - CEO, President & Non-Independent Director Joseph Scheffler - Interim Chief Financial ...
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
“This is the first major study to compare the effect of two common diabetes treatments — GLP-1 medicines and metformin — on dementia risk, using health records from more than 174,000 people. The ...
Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...